Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Histopathology|June 20, 2020
Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS ScoreMiglena Komforti, Sunil S Badve, Bryan Harmon, et al.
Frontiers in Pharmacology|June 14, 2019
The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX<sup>®</sup> Recurrence Score in ER-Positive Invasive Breast CancersPascale A Cohen, Olivier Loudig, Christina Liu, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 1, 2022
EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor ResponseYujun Gan, Yungtai Lo, Della Makower, et al.
International Journal of Breast Cancer|January 24, 2014
Utilization of Oncotype DX in an Inner City Population: Race or Place?Amber A Guth, Susan Fineberg, Kezhen Fei, et al.
Histopathology|December 9, 2017
Invasive mucinous carcinoma of the breast and response patterns after neoadjuvant chemotherapy (NAC)Rosemarie Didonato, Nella Shapiro, Tova Koenigsberg, et al.
Plos One|December 3, 2020
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancerYiyu Zou, Susan Fineberg, Alexander Pearlman, et al.
Breast Cancer Research and Treatment|February 23, 2026
Impact of immune-related adverse events on response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: a single-institution retrospective studyMichelle Sterpi, Nechama Dreyfus, Yungtai Lo, et al.
Cureus|October 17, 2022
Invasive Lobular Cancer Arising in a Surgical Scar From Lumpectomy for a Previous Invasive Ductal Cancer of the BreastRichard Adam, Mira Herman, Laura Hodges, et al.
Breast Cancer Research : BCR|September 12, 2022
MiRNA expression deregulation correlates with the Oncotype DX<sup>®</sup> DCIS scoreOlivier Loudig, Megan I Mitchell, Iddo Z Ben-Dov, et al.
Human Pathology|November 16, 2023
Pathological response in mucinous carcinoma of breast after neoadjuvant therapy - a multi-institutional studyHaiying Zhan, Susan Fineberg, Peter Podany, et al.
Pageof 6